Kennedy Starts a Push to Help Americans Quit Antidepressants

Key Points:

• Health Secretary Robert F. Kennedy Jr. announced initiatives aimed at reducing the prescription of selective serotonin reuptake inhibitors (SSRIs), a widely used class of antidepressants known for being difficult to quit.
• SSRIs, including medications like Zoloft, Lexapro, Paxil, and Prozac, are currently taken by about one in six U.S. adults, and have been popular due to fewer side effects and ease of prescription by general practitioners.
• Many patients experience withdrawal symptoms from SSRIs, such as "brain zaps," restlessness, and flu-like symptoms, often with insufficient clinical support during discontinuation.
• The new measures include clinician training, updated reimbursement policies, and clinical guidelines encouraging support for patients tapering off SSRIs and promoting nonpharmaceutical treatments like therapy, nutrition, and exercise.
• Kennedy emphasized that psychiatric medications will no longer be the default treatment but one option among many, with transparency and clear strategies for discontinuation when appropriate.